Lataa...
Pharmacology of Recombinant Adeno-associated Virus Production
Recombinant adeno-associated viral (rAAV) vectors have been used in more than 150 clinical trials with a good safety profile and significant clinical benefit in many genetic diseases. In addition, due to their ability to infect non-dividing and dividing cells and to serve as efficient substrate for...
Tallennettuna:
| Julkaisussa: | Mol Ther Methods Clin Dev |
|---|---|
| Päätekijät: | , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
American Society of Gene & Cell Therapy
2018
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5908265/ https://ncbi.nlm.nih.gov/pubmed/29687035 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.omtm.2018.01.002 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|